Carol Stuckley, MBA is a global, strategic financial executive with proven success leading finance teams and creating shareholder value for healthcare companies.
Carol recently served as Chief Financial Officer and Senior Vice President at Healthcare Payment Specialists, LLC, leading to its acquisition by TransUnion, Inc. Her previous roles include Vice President, Finance North America of Galderma Laboratories, L.P. (Nestle Skin Health), and during her close to 23-year global career at Pfizer, Inc., she most recently served as Vice President, Assistant Treasurer and Corporate Officer.
Carol currently serves on the board of Transgene, a French biotechnology company traded on the Euronext (Paris) exchange. She previously served on the board of Epizyme, Inc., a US biopharmaceutical company traded on NASDAQ, and on the board of Ipsen S.A., a French pharmaceutical company traded on the Euronext (Paris) exchange. During her tenure at Pfizer, she served on several Pfizer Luxembourg company boards.
Carol holds a Master of Arts in Economics and an MBA in International Finance from Temple University’s Fox Business School and a BA with Distinction in Economic and French from the University of Delaware.
